Two year ago, Dr. Ryan Cole was reporting an “up-tick” of cancer from observations made from his pathology practice. Just this month (April 2024) a study from Japan confirmed Dr. Cole’s initial observation with a study titled:
Increased Age-Adjusted Cancer Mortality After the Third mRNA-Lipid Nanoparticle Vaccine Dose During the COVID-19 Pandemic in Japan.
The study explores changes in age-adjusted mortality rates (AMRs) for various cancer types in Japan during the COVID-19 pandemic, specifically after administering the third dose of mRNA-LNP vaccines. The study uses data from 2020 to 2022 and compares it with pre-pandemic trends to identify any excess mortalities associated with cancer.
The findings indicate no significant excess mortality in 2020, but a notable increase in cancer mortality in 2021 and a further rise in 2022 following the mass vaccination campaigns.
Key insights include the age-adjusted mortality rates (AMRs) for the four leading causes of cancer deaths—lung, colorectal, stomach, and liver cancers—were initially declining until the first year of the pandemic in 2020. However, this downward trend stalled, and began to reverse, showing an increase in mortality rates in 2021 and 2022. And the identification of significant excess mortalities for cancers such as ovarian cancer, leukemia, prostate cancer, lip/oral/pharyngeal cancer, and pancreatic cancer after the third vaccine dose.
The study suggests potential biological mechanisms related to the mRNA-LNP vaccine that may contribute to increased cancer mortality, emphasizing the need for further research to fully understand the implications of these findings. The study is significant as it highlights a potential public health issue that may require adjustments in vaccination and cancer screening strategies.
The study can be found here.
Dear God...We are so FUCKED!